Search Results 81-90 of 17096 for monoclonal antibody

1. Muromonab-cd3 (intravenous route) - Mayo Clinic

   Muromonab-CD3 is a monoclonal antibody. It is used to reduce the body's natural immunity in patients who receive organ (for example, kidney) transplants ...

2. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

   GA101 is an anti-CD20 humanized and glyco-engineered monoclonal antibody. GA101 has been shown to have increased antibody-dependent cellular cytotoxicity ...

3. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

   Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

4. Multiple myeloma - Symptoms and causes - Mayo Clinic

   The myeloma cells continue trying to make antibodies, as healthy plasma cells do. But the body can't use these antibodies, called monoclonal proteins or M ...

5. Rituximab (intravenous route) - Mayo Clinic

   It helps the immune system destroy cancer cells. Rituximab injection is a monoclonal antibody. Rituximab injection is used together with other medicines (eg, ...

6. Mayo Clinic research finds immune system responds to mRNA treatment for cancer

   Dong and his team produced an immune system protein in the lab ― a monoclonal antibody ― that can detect the protein levels in tumor tissues. The goal was ...

7. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types - Mayo Clinic

   ... monoclonal antibody, and compare them with clinical outcomes. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

8. Publications - Raymund R. Razonable, M.D. - Mayo Clinic

   ... monoclonal antibody therapy in solid organ transplant recipients. J Med Virol. 2023 Jun; 95 (6):e28885. View PubMed; Ordaya EE, Higgins EM, Vergidis P ...

9. Mayo Clinic expert provides perspective on FDA approval of another experimental Alzheimer's drug

   A monoclonal antibody, lecanemab, shows promise in removing amyloid plaques from the brain, according to phase 3 trial results. Amyloid plaques are one of ...

10. Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Brentuximab vedotin is a combining monoclonal antibody with an anticancer drug that binds to a protein on the surface of lymphoma cells called cluster of ...